Arun Swaminathan
Chief Executive Officer · Coya Therapeutics, Inc.
- 2024
- Jan 26, 2026
- 3
Summary
Latest filing:
Arun Swaminathan is Chief Executive Officer of Coya Therapeutics, Inc. (COYA). 3 SEC Form 4 filings on record going back to 2024, most recently on 26 January 2026. Most recent open-market trade: bought $37K of COYA on 13 November 2024. Lifetime open-market purchases: $73K.
Recent transactions
2The latest 2 SEC Form 4 transactions reported by Arun Swaminathan.
Trading pattern
InsiderAlpha's records for Arun Swaminathan go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. The typical open-market purchase is $37K (2 buys totaling $73K). The largest single buy on record is $37K of COYA in 2024. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Arun Swaminathan. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fred Grossman - $20K in COYA purchases and sales on record
- David S. Snyder - $13K in COYA purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Arun Swaminathan?
Arun Swaminathan is a corporate insider, tracked as Chief Executive Officer of Coya Therapeutics, Inc. (COYA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Arun Swaminathan last file a Form 4?
The most recent primary Form 4 on record is dated 26 January 2026, one of 3 filings going back to 2024.
Has Arun Swaminathan been buying or selling stock?
Recorded transactions: 2 open-market purchases ($73K) and 0 open-market sales across all tracked filings.